Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2019-03-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
中航证券有限公司关于公司首次公开发行股票募集资金2018年度存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring institution (中航证券有限公司) regarding the storage and usage of funds raised from the company's initial public offering (IPO) in 2018. It includes specific financial figures about the amount raised, usage of funds, bank accounts holding the funds, compliance with regulatory requirements, and the sponsor's verification and opinion on the proper use of the funds. The document references regulatory approvals and compliance with securities laws and stock exchange rules. It is a specialized audit or verification report focused on the use of IPO proceeds rather than a full annual report or earnings release. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and results of regulatory checks excluding full annual reports. The document length (5830 characters) and content confirm it is a substantive report, not merely an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2018
2019-03-25 Chinese
中航证券有限公司关于公司2018年度跟踪报告
Regulatory Filings Classification · 95% confidence The document is titled as a '2018年度跟踪报告' (2018 Annual Tracking Report) issued by 中航证券有限公司 (China Aviation Securities Co., Ltd.) regarding 健帆生物科技集团股份有限公司 (Jianfan Biotechnology Group Co., Ltd.). It details the sponsor's work overview, findings, company and shareholder commitments, and other matters related to the sponsor's supervision and compliance activities during the year 2018. The document includes no financial statements or detailed financial data but focuses on the sponsor's review, supervision, and compliance monitoring activities. It is not an annual report (10-K), audit report, or earnings release. It is a report related to the sponsor's ongoing monitoring and compliance oversight, which aligns with the nature of a Regulatory Filing (RNS) as it does not fit other specific categories and is a compliance-related report. The document length is 2557 characters, relatively short and focused on sponsor's tracking and compliance work rather than financial results or governance changes. Therefore, the best classification is Regulatory Filings (RNS).
2019-03-25 Chinese
2018年度独立董事述职报告（杨柏）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2018" from a company. It details the independent director's attendance at board and shareholder meetings, participation in board committees, opinions on major matters, on-site investigations, and training activities during the year 2018. The content focuses on the director's duties, opinions, and compliance with governance rules rather than presenting financial statements or audit results. It is a formal report by an independent director about their role and activities, which aligns with Board/Management Information filings that announce or report on changes or activities related to the board or management. The document length is about 3061 characters, which is relatively short and focused on governance and director duties rather than financial results or audit. Therefore, the best fitting category is Board/Management Information (MANG).
2019-03-25 Chinese
2018年监事薪酬的确定以及2019年监事薪酬的方案
Remuneration Information Classification · 95% confidence The document details the remuneration determination for supervisors (监事) for the year 2018 and the remuneration plan for 2019. It includes specific salary figures, payment standards, and references to company governance documents such as the Articles of Association and the remuneration management system. The document is a report on compensation for company supervisors, which fits the definition of Remuneration Information filings. It is not an announcement of a report, nor a general regulatory filing, but a detailed remuneration report. Therefore, the appropriate classification is DEF 14A (Remuneration Information). The document length and content support a high confidence in this classification.
2019-03-25 Chinese
2018年非独立董事、高级管理人员薪酬的确定以及2019年非独立董事、高级管理人员薪酬的方案
Remuneration Information Classification · 95% confidence The document details the determination of remuneration for non-independent directors and senior management for the years 2018 and 2019. It includes specific salary figures, bonus structures, and proposals for the upcoming year. The content focuses exclusively on compensation information for executives and directors, which aligns with the definition of Remuneration Information filings. The document is relatively short (1243 characters) and does not present full financial statements or broader management discussion, so it is not an Annual Report or Management Report. It is not an announcement of voting results or a proxy statement, but rather a detailed report on compensation. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2019-03-25 Chinese
2018年监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2018 年监事会工作报告" which translates to "2018 Supervisory Board Work Report". It details the supervisory board's activities, meetings, opinions on the company's legal compliance, financial status, fundraising usage, related party transactions, external guarantees, internal control evaluations, and insider information management for the year 2018. It also outlines the supervisory board's work plan for 2019. The content is a detailed report from the supervisory board rather than an announcement or a brief summary. It does not fit the categories of Annual Report (10-K), Interim Report (IR), or Audit Report (AR) since it focuses on supervisory board activities and oversight rather than full financial statements or audit opinions alone. It is not a regulatory filing or announcement. The document is a management-related report focusing on supervisory board oversight and activities, which aligns best with the category of Management Reports (MDA).
2019-03-25 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.